Qiang (nmn) Gao - 18 Mar 2026 Form 3 Insider Report for SINOVAC BIOTECH LTD (SVA)

Reporting relationship: Chief Operation Officer
Issuer ticker: SVA
Reported as of: 18 Mar 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 18 Mar 2026, 08:29:25 UTC
Source filing: View source filing
Reporting owner signature: /s/ Jia Zhao, Attorney-in-Fact

Key filing fact

Qiang (nmn) Gao filed Form 3 for SINOVAC BIOTECH LTD (SVA) on 18 Mar 2026.

Key facts

This page summarizes Qiang (nmn) Gao's Form 3 filing for SINOVAC BIOTECH LTD (SVA).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 18 Mar 2026, 08:29.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002118806 Primary reporting owner

GAO QIANG (NMN)

Relationship: Chief Operation Officer
Address: SEE REMARKS, BEIJING, CHINA
Signature: /s/ Jia Zhao, Attorney-in-Fact
Signature date: 18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SVA holding

Common shares, par value $0.001 per share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 230,000
Date: 18 Mar 2026
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

SEC remarks

The full street address is No. 21 Tianfu Road, Zhongguancun Science Park Daxing Biomedical Industrial Base, Daxing District. Exhibit 24 - Power of Attorney